Pricing Log in Create free account

Solid Biosciences Inc. (SLDB) vs Syndax Pharmaceuticals, Inc. (SNDX)

Solid Biosciences Inc. and Syndax Pharmaceuticals, Inc. are both Biotechnology companies. Solid Biosciences Inc. and Syndax Pharmaceuticals, Inc. are of similar size ($863.4M and $848.2M). Solid Biosciences Inc. has the higher net margin (0.00% vs −72.4%) and the higher return on invested capital (0.00% vs −83.4%). Across the 15 metrics below, Solid Biosciences Inc. leads on 9 and Syndax Pharmaceuticals, Inc. on 6.

Valuation

Metric SLDB SNDX Biotechnology median
P/E n/m n/m 11.58
P/S 101.91 2.98 9.61
P/B 3.35 n/m 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m n/m 0.72
EV/Sales 70.86 3.58 9.43
Earnings yield (23.55%) (24.59%) (32.28%)
Free cash flow yield (17.47%) (20.60%) (22.27%)

Profitability

Metric SLDB SNDX Biotechnology median
Gross margin 0.00% 92.21% 68.81%
Operating margin 0.00% (61.72%) 0.00%
Net margin 0.00% (72.38%) 0.00%
Free cash flow margin 0.00% (61.36%) 0.00%
Return on equity (76.87%) (426.43%) (50.30%)
Return on assets (64.86%) (33.67%) (45.47%)
Return on invested capital 0.00% (83.42%) 0.00%

Growth

Metric SLDB SNDX Biotechnology median
Revenue growth (TTM) — 159.46% 6.78%
EPS growth (last fiscal year) 34.97% 11.56% 29.88%
Revenue growth, 5-year CAGR — 157.68% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SLDB SNDX Biotechnology median
Debt to equity 0.00 (34.24) 0.00
Current ratio 11.99 4.69 4.74
Net debt to EBITDA 1.05 0.25 1.01

Dividend

Metric SLDB SNDX Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric SLDB SNDX Biotechnology median
Market cap 848.24m 863.37m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack